Literature DB >> 14645693

Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas.

A Kovács1, J Dhillon, R A Walker.   

Abstract

AIMS: To compare the expression of the cell adhesion molecules P-cadherin, N-cadherin, and E-cadherin in invasive and in situ breast carcinomas relative to clinicopathological features (size, node status, type, grade, and receptors) to determine whether expression patterns relate to specific tumour characteristics.
METHODS: Using immunohistochemistry, 110 invasive and in situ breast carcinomas were examined for the presence, extent, and localisation of all three cadherins. Findings were related to tumour size, type, grade, node status, oestrogen (ER), progesterone, and epidermal growth factor receptor (EGFR) expression for invasive carcinomas and to grade and receptors for in situ carcinomas.
RESULTS: P-cadherin was detected in 40% of invasive carcinomas, N-cadherin in 30%, and E-cadherin in 81%. For invasive carcinomas, the presence of P-cadherin significantly correlated with high grade, lack of ER and presence of EGFR, but not tumour size or node status. Carcinomas containing P-cadherin could be put into three categories dependent upon receptor and E-cadherin profile. There were no correlations between E/N-cadherin and size, grade, node status, or receptors. Three of 16 infiltrating lobular carcinomas expressed cytoplasmic but none membranous E-cadherin, and P-cadherin and N-cadherin were present in four carcinomas of this type. E-cadherin was found in all ductal carcinomas in situ, P-cadherin in a proportion of high grade tumours, and N-cadherin in a mixture of grades.
CONCLUSION: P-cadherin but not E/N-cadherin expression in breast carcinomas shows a strong correlation with higher grade (poorer differentiation), lack of ERs, and presence of EGFR, and its expression may aid in the further subdivision of high grade carcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645693      PMCID: PMC1187349          DOI: 10.1136/mp.56.6.318

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  30 in total

1.  Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast.

Authors:  C E Gillett; D W Miles; K Ryder; D Skilton; R D Liebman; R J Springall; D M Barnes; A M Hanby
Journal:  J Pathol       Date:  2001-04       Impact factor: 7.996

2.  P-cadherin expression in breast carcinoma indicates poor survival.

Authors:  A Peralta Soler; K A Knudsen; H Salazar; A C Han; A A Keshgegian
Journal:  Cancer       Date:  1999-10-01       Impact factor: 6.860

3.  The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma.

Authors:  C Gamallo; G Moreno-Bueno; D Sarrió; F Calero; D Hardisson; J Palacios
Journal:  Mod Pathol       Date:  2001-07       Impact factor: 7.842

4.  Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinomas.

Authors:  S A Chappell; S M Johnson; J A Shaw; R A Walker
Journal:  J Pathol       Date:  2000-10       Impact factor: 7.996

5.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast.

Authors:  Joana Paredes; Fernanda Milanezi; Leda Viegas; Isabel Amendoeira; Fernando Schmitt
Journal:  Virchows Arch       Date:  2002-01       Impact factor: 4.064

7.  P-cadherin as a marker in the differential diagnosis of breast lesions.

Authors:  A Kovács; R A Walker
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

8.  N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression.

Authors:  M T Nieman; R S Prudoff; K R Johnson; M J Wheelock
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

9.  E-cadherin as a prognostic indicator in primary breast cancer.

Authors:  C Parker; R S Rampaul; S E Pinder; J A Bell; P M Wencyk; R W Blamey; R I Nicholson; J F Robertson
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

10.  CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.

Authors:  C Jones; A V Nonni; L Fulford; S Merrett; R Chaggar; V Eusebi; S R Lakhani
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

View more
  19 in total

1.  Perceived body shape, standardized body-mass index, and weight-specific quality of life of African-American, Caucasian, and Mexican-American adolescents.

Authors:  Todd C Edwards; Donald L Patrick; Anne M Skalicky; Yi Huang; Andrea D Hobby
Journal:  Qual Life Res       Date:  2011-09-30       Impact factor: 4.147

2.  Expression of classical cadherins in the cerebellar anlage: quantitative and functional aspects.

Authors:  Michael Gliem; Gunnar Weisheit; Kirsten D Mertz; Elmar Endl; John Oberdick; Karl Schilling
Journal:  Mol Cell Neurosci       Date:  2006-10-16       Impact factor: 4.314

3.  Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells.

Authors:  Keiki Nagaharu; Xinhui Zhang; Toshimichi Yoshida; Daisuke Katoh; Noriko Hanamura; Yuji Kozuka; Tomoko Ogawa; Taizo Shiraishi; Kyoko Imanaka-Yoshida
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases.

Authors:  Gábor Cserni; Giuseppe Floris; Nektarios Koufopoulos; Anikó Kovács; Afroditi Nonni; Peter Regitnig; Anders Stahls; Zsuzsanna Varga
Journal:  Virchows Arch       Date:  2017-05-20       Impact factor: 4.064

5.  P-cadherin expression and basal-like subtype in breast cancers.

Authors:  N Liu; Q Yu; T J Liu; Estifanos P Gebreamlak; S L Wang; R J Zhang; J Zhang; Y Niu
Journal:  Med Oncol       Date:  2012-04-01       Impact factor: 3.064

6.  Effect of NS398 on metastasis-associated gene expression in a human colon cancer cell line.

Authors:  Xue-Qin Gao; Jin-Xiang Han; Hai-Yan Huang; Bao Song; Bo Zhu; Chang-Zheng Song
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

7.  Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.

Authors:  K Lundgren; B Nordenskjöld; G Landberg
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

8.  P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27.

Authors:  Mariel A Fanelli; Magdalena Montt-Guevara; Angela M Diblasi; Francisco E Gago; Olga Tello; F Darío Cuello-Carrión; Eduardo Callegari; Maria A Bausero; Daniel R Ciocca
Journal:  Cell Stress Chaperones       Date:  2008-03-05       Impact factor: 3.667

Review 9.  Epithelial to mesenchymal transition in head and neck squamous cell carcinoma.

Authors:  Ashley Smith; Theodoros N Teknos; Quintin Pan
Journal:  Oral Oncol       Date:  2012-11-19       Impact factor: 5.337

10.  Cadherin cell adhesion system in canine mammary cancer: a review.

Authors:  Adelina Gama; Fernando Schmitt
Journal:  Vet Med Int       Date:  2012-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.